Tampa, FL – According to filings with the U.S. Securities and Exchange Commission, H-Cyte is raising $2,880,195.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Jeremy Daniel played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About H-Cyte

H-Cyte is a corporate management board that focuses on long-term health solutions that inspire longevity and improve quality of life. H-CYTE currently owns and manages multiple health care provider and product brands designed to improve the lives of people around the world. Our board of directors is comprised of medical, research and corporate executives from a variety of industries who seek to bring innovative technology and medical solutions to market.

To learn more about H-Cyte, visit http://www.hcyte.com/

Contact:
Jeremy Daniel, Chief Financial Officer
844-633-6839
jdaniel@hcyte.com
https://www.linkedin.com/in/jddaniel/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved